171 related articles for article (PubMed ID: 19131794)
1. Fibrolamellar hepatocellular carcinoma in an infant and literature review.
Cruz O; Laguna A; Vancells M; Krauel L; Medina M; Mora J
J Pediatr Hematol Oncol; 2008 Dec; 30(12):968-71. PubMed ID: 19131794
[TBL] [Abstract][Full Text] [Related]
2. Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
[TBL] [Abstract][Full Text] [Related]
3. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
Bhaijee F; Locketz ML; Krige JE
S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
[TBL] [Abstract][Full Text] [Related]
4. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
Lee J; Park JO; Kim WS; Park SH; Park KW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Joh J; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Park K
Cancer Chemother Pharmacol; 2004 Nov; 54(5):385-90. PubMed ID: 15248028
[TBL] [Abstract][Full Text] [Related]
6. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH].
von Schweinitz D; Bürger D; Weinel P; Mildenberger H
Klin Padiatr; 1992; 204(4):214-20. PubMed ID: 1381454
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.
Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H
Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237
[TBL] [Abstract][Full Text] [Related]
9. [Multiorgan resection in combination with intraoperative, hyperthermic chemotherapy in recurrent fibrolamellar hepatocellular carcinoma. An individual therapeutic concept for a 21-year-old patient].
Braune C; Fangmann J; Scheumann GF; Klempnauer J
Zentralbl Chir; 2001 Apr; 126(4):318-21; discussion 322. PubMed ID: 11370396
[TBL] [Abstract][Full Text] [Related]
10. Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: a case-control study.
Chau GY; Lui WY; Tsay SH; Chao Y; King KL; Wu CW
Ann Surg Oncol; 2006 Oct; 13(10):1329-37. PubMed ID: 16897271
[TBL] [Abstract][Full Text] [Related]
11. Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy.
Ferrari D; Di Maria G; Fazio N; Codecà C; Fiore J; Luciani A; Oldani S; Maggioni M; Foa P
Anticancer Drugs; 2008 Sep; 19(8):837-40. PubMed ID: 18690097
[TBL] [Abstract][Full Text] [Related]
12. [Fibrolamellar liver carcinoma: report of two cases and review of the literature].
Butte JM; Waugh E; Meneses M; Pruzzo R; Carvallo C; Redondo F; Suárez C; Parada H; Amaral H; de La Fuente H
Rev Med Chil; 2009 Mar; 137(3):394-400. PubMed ID: 19621182
[TBL] [Abstract][Full Text] [Related]
13. Adult type vs. Childhood hepatocellular carcinoma--are they the same or different lesions? Biology, natural history, prognosis, and treatment.
Czauderna P
Med Pediatr Oncol; 2002 Nov; 39(5):519-23. PubMed ID: 12228910
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic artery infusion chemotherapy with cisplatin and adriamycin in combination with angiotensin-II in the treatment of malignant liver tumors].
Morita S; Matsumoto S; Odani R
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):689-95. PubMed ID: 2451473
[TBL] [Abstract][Full Text] [Related]
15. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
[TBL] [Abstract][Full Text] [Related]
16. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report.
Okano A; Hajiro K; Takakuwa H; Kobashi Y
Am J Gastroenterol; 1998 Jul; 93(7):1144-5. PubMed ID: 9672347
[TBL] [Abstract][Full Text] [Related]
17. Successful multimodal treatment for aggressive metastatic and recurrent fibrolamellar hepatocellular carcinoma in a child.
Okur A; Eser EP; Yilmaz G; Dalgiç A; Akdemir ÜÖ; Oğuz A; Karadeniz C; Akyol G; Demiroğullari B; Boyunağa Ö; Pinarli FG
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e328-32. PubMed ID: 24608073
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
[TBL] [Abstract][Full Text] [Related]
19. [Complete disappearance with oral UFT administration of recurrent hepatocellular carcinoma of the remnant liver and multiple lung metastasis after hepatic resection].
Matsushita A; Hanazaki K; Noike T; Nakagawa K; Misawa R; Nakata T; Nomura K; Kobayashi A; Miwa S; Miyagawa S; Kawasaki S
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1327-32. PubMed ID: 14518415
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.
Ikeda M; Okusaka T; Ueno H; Morizane C; Kojima Y; Iwasa S; Hagihara A
Jpn J Clin Oncol; 2008 Oct; 38(10):675-82. PubMed ID: 18716041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
